Viridian Therapeutics, Inc.\DE

VRDN Nasdaq SEC CIK 1590750
Follow Viridian Therapeutics, Inc.\DE Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $25.8M −63.5% vs same quarter last year
Net income −$101.2M −192.5% vs same quarter last year
EPS, diluted -
Operating cash flow −$92.8M −9.6% vs same quarter last year
Revenue by quarter
$72K
$72K
$75K
$70.6M
$132K
$141K
$284K
$25.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$70.8M−$342.6M
FY24$302K−$269.9M
FY23$314K−$237.7M
FY22$1.8M−$129.9M
FY21$3M−$79.4M
FY20$1.1M−$110.7M
FY19$4.5M−$41.9M
FY18$8.4M−$32.7M
FY17$4M−$26.5M
FY16$3.5M−$17.3M
FY15$5.7M−$11.3M
FY14$6.5M−$7.9M
FY13$5.5M−$2.2M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100000%−75000%−50000%−25000%0%25000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−512.9%−483.6%
FY24-−99018.2%−89370.9%
FY23-−81035%−75700.6%
FY22-−7579.2%−7330.7%
FY21-−2690.8%−2679.7%
FY20-−10512.4%−10544.3%
FY19-−941%−938.6%
FY18-−394.5%−390%
FY17-−662.8%−662.3%
FY1626.7%−488.6%−496.8%
FY1556.7%−196.1%−198.5%
FY1448.1%−105.9%−121.7%
FY1349.4%−3.6%−39.3%
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$276.9M
FY24−$232.8M
FY23−$185.1M
FY22−$94.6M
FY21−$54.9M
FY20−$29.8M
FY19−$36.1M
FY18−$27.3M
FY17−$28.4M
FY16−$15M
FY15−$7M
FY14−$2.5M
FY13−$1.2M
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Viridian Therapeutics, Inc.\DE
  • Healthcare median
−100000%−75000%−50000%−25000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearViridian Therapeutics, Inc.\DEHealthcare median
FY25−483.6%−30.6%
FY24−89370.9%−47%
FY23−75700.6%−58%
FY22−7330.7%−80.4%
FY21−2679.7%−71.9%
FY20−10544.3%−62.2%
FY19−938.6%−46.3%
FY18−390%−49.6%
FY17−662.3%−45.9%
FY16−496.8%−36%
FY15−198.5%−38.4%
FY14−121.7%−35.5%
FY13−39.3%−37.1%
FY12-−29.1%